A 39-year-old woman expresses concerns about receiving the recombinant zoster vaccine, stating she is too young. She is otherwise healthy. According t...

Question

A 39-year-old woman expresses concerns about receiving the recombinant zoster vaccine, stating she is too young. She is otherwise healthy. According to NACI recommendations, at what age should immunocompetent adults routinely be offered recombinant zoster vaccine for prevention of shingles?

Accepted Answer

At 50 years of age.

Answer

At 40 years of age.

Answer

At 45 years of age.

Answer

At 60 years of age.

Answer

Only after a first episode of shingles.

ca-mccqe1 MCQ (SBA): Herpes zoster vaccination

A 39-year-old woman expresses concerns about receiving the recombinant zoster vaccine, stating she is too young. She is otherwise healthy. According to NACI recommendations, at what age should immunocompetent adults routinely be offered recombinant zoster vaccine for prevention of shingles?